December 10, 2019

While the CLL Society team has been more than busy at ASH 2019 in Orlando, Florida doing interviews, reviewing the major CLL research and presenting our abstract, this week we are continuing to count down our 10 ten CLL abstracts from ASCO 2019.

#8 Surviving CLL is only part of the story if we are going to succumb to second cancers. This ASCO abstract studies second cancers in CLL patients on ibrutinib or acalabrutib .

In his #7 of the top 10 CLL abstracts from ASH, Dr. Koffman reviews the encouraging data on the benefits of transplants for Richter’s Transformations .

Guest writer, Brian Maxson is a CLL patient and an inquisitive engineer who lays out the points Dr. Stilgenbauer made at the ERIC meeting about the timely topic of sequential versus combination therapies in CLL .

Have you started your holiday shopping?

Don’t forget you can support CLL Society at no cost to you! How? Simply type smile.amazon.com into your browser and select CLL Society as your charity. Shop like you normally do, and Amazon will automatically donate a portion of the purchase price to CLL Society.

These small amounts add up, and we are so grateful for every dollar, which will help us provide important education and services to the CLL patient community.

Of course, you can always make a direct donation as well.

For those already donating through Amazon Smile, THANK YOU!

The 1st 2020 post ASH Patient Educational Forum at City Of Hope on Jan. 11

We are excited to be returning to City of Hope on the morning of January 11 for our 5th Annual Post ASH Patient and Caregiver Education Forum featuring the latest news from ASH presented by, among others, CLL superstars, Drs. Rosen and Danilov. View more information and register here for this free CLL-specific educational forum.

Watch our latest CLL Society Webinar Archive

If you missed the CLL Society Webinar, “Veterans with CLL: How to Get the Benefits and Care You Deserve,” you can find the webinar recording and presentation slides linked here for this important topic.

Test Before Treat™

Test Before Treat™ CLL Experts, Doctors Mato, Stilgenbauer, Furman, Jain, and Davids endorse Test Before Treat™. Find out what you need to know before every treatment.

As part of our campaign for Test Before Treat™ to make all patients aware of the importance of testing before treatment, we are looking for your statement on how your testing before treatment, or sadly, the lack thereof, influenced your CLL management. Please drop us one or two lines at support@cllsociety.org .

Patients and Caregivers Needed for Surveys

Pillar Patient Advocates has a paid ($150) opportunity for 24 patients of varying stages of CLL, who have been diagnosed within the past three years. Find out more here .

Focus Pointe Global is currently recruiting CLL patients for an upcoming medical conditions study. Compensation potential of $1000+. Find out more here .

Our CLL Experts Will See You Online!

Would you like a second look at your CLL? A generous grant funds our Expert Access Program, allowing you to see a world-renowned CLL physician- at no cost- for a second opinion, using our easy online platform . This program is open to all U.S. patients with a CLL diagnosis, and you are welcome to apply here. If you have used the program before, you may reapply if you need new clinical advice.

CLL Society Support Group Meetings Coming Up!